Diagnostics

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...

Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply

Five-year renewable agreement secures reliable cGMP rhenium-186 (Re-186) supply for late-stage clinical and commercial forecastsAUSTIN, Texas, Dec. 03, 2024 (GLOBE...

GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024

Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices,...

Dental Practice Management Market Surges to USD 5.73 Billion by 2030, Propelled by 10.9% CAGR – Verified Market Reports®

The dental practice management market is driven by the increasing prevalence of oral health issues, a growing demand for cosmetic...

error: Content is protected !!